Related references
Note: Only part of the references are listed.Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
Francesco Lasorsa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
Giuseppe Lucarelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC
Hui Yang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2022)
Lipid metabolism reprogramming in renal cell carcinoma
Gioia Heravi et al.
CANCER AND METASTASIS REVIEWS (2022)
SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC
Xiaofeng Li et al.
CANCER LETTERS (2022)
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma
Ken Tanaka et al.
ONCOLOGY REPORTS (2022)
Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer
Hiroshi Nakayama et al.
PROSTATE (2022)
New approach in determination of urinary diagnostic markers for prostate cancer by MALDI-TOF/MS
M. Buszewska-Forajta et al.
TALANTA (2022)
Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma
Huijie Zhang et al.
JOURNAL OF CANCER (2022)
TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis
Caizhi Chen et al.
BMC CANCER (2022)
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review
Davide Loizzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
Nicola Antonio di Meo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Inhibition of Stearoyl-CoA Desaturase by Sterculic Oil Reduces Proliferation and Induces Apoptosis in Prostate Cancer Cell Lines
Eric Francisco Contreras-Lopez et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2022)
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies
Matteo Ferro et al.
UROLOGIA INTERNATIONALIS (2022)
HIF-2 alpha-induced upregulation of CD36 promotes the development of ccRCC
Meng Liao et al.
EXPERIMENTAL CELL RESEARCH (2022)
Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature
Martina Monti et al.
BIOMEDICINES (2022)
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
Nicola Antonio di Meo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
Giuseppe Lucarelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival
Matteo Santoni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients
Qinghua Wang et al.
CANCERS (2022)
Fatty acid metabolism-related signature predicts survival in patients with clear cell renal carcinoma
Rongjiang Wang et al.
Aging-US (2022)
Omics in urology: An overview on concepts, current status and future perspectives
Andrea Panunzio et al.
UROLOGIA JOURNAL (2021)
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer
Margaret M. Centenera et al.
CANCER RESEARCH (2021)
Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway
Shan Zhu et al.
LIFE SCIENCES (2021)
The association of prostatic lipids with progression, racial disparity and discovery of biomarkers in prostate cancer
Xinchun Zhou et al.
TRANSLATIONAL ONCOLOGY (2021)
Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls
Denise Wolrab et al.
SCIENTIFIC REPORTS (2021)
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma
Guangzhen Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
Statin use and the risk of renal cell carcinoma: national cohort study
Yu-Ching Chou et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2020)
Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases
Mario De Piano et al.
ONCOGENE (2020)
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma
Giuseppe Stefano Netti et al.
AGING-US (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma
Xiang Liu et al.
FRONTIERS IN ONCOLOGY (2020)
FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
Zhi Cao et al.
DISEASE MARKERS (2020)
Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites
Andras Franko et al.
CANCERS (2020)
Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer
Paavo Raittinen et al.
SCIENTIFIC REPORTS (2020)
Investigation of Plasma Metabolic and Lipidomic Characteristics of a Chinese Cohort and a Pilot Study of Renal Cell Carcinoma Biomarker
Xiaoyan Liu et al.
FRONTIERS IN ONCOLOGY (2020)
The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins
Christopher Murphy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
An Amplified Fatty Acid-Binding Protein Gene Cluster in Prostate Cancer: Emerging Roles in Lipid Metabolism and Metastasis
Rong-Zong Liu et al.
CANCERS (2020)
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
Giuseppe Lucarelli et al.
METABOLITES (2020)
Cytotoxicity and Radiosensitizing Activity of the Fatty Acid Synthase Inhibitor C75 Is Enhanced by Blocking Fatty Acid Uptake in Prostate Cancer Cells
Colin Rae et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma
Yijiao Yuan et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells
Silvia Bombelli et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Binlu Huang et al.
NATURE METABOLISM (2020)
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer
Matteo Ferro et al.
WORLD JOURNAL OF UROLOGY (2019)
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
Matthew J. Watt et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment
Roberto Tamma et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update
Giuseppe Lucarelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferation
Eva Neumann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
Joseph Longo et al.
MOLECULAR METABOLISM (2019)
Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease
Marta Kordalewska et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
Ana Rita Lima et al.
BRITISH JOURNAL OF CANCER (2019)
Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancers
Andreas Mock et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Racial differences in distribution of fatty acids in prostate cancer and benign prostatic tissues
Xinchun Zhou et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer
Seher Balaban et al.
MOLECULAR CANCER RESEARCH (2019)
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
Giorgia Zadra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
Adele Chimento et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
Karen Griselda de la Cruz Lopez et al.
FRONTIERS IN ONCOLOGY (2019)
USP17 Suppresses Tumorigenesis and Tumor Growth through Deubiquitinating AEP
Xi Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux
Wen-Jun Shen et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma
Nobuhisa Hagiwaraa et al.
CANCER LETTERS (2018)
Activation of AMPK by simvastatin inhibited breast tumor angiogenesis via impeding HIF-1-induced pro-angiogenic factor
Ji-Chang Wang et al.
CANCER SCIENCE (2018)
LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway
Guanghua Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer
Yaping Shao et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer
Etienne Audet-Walsh et al.
MOLECULAR CANCER RESEARCH (2018)
Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism
Jordan M. Thompson et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
Jingjing Chen et al.
NATURE GENETICS (2018)
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Ming Chen et al.
NATURE GENETICS (2018)
Clinical implications of PTEN loss in prostate cancer
Tamara Jamaspishvili et al.
NATURE REVIEWS UROLOGY (2018)
Furan and p-xylene as candidate biomarkers for prostate cancer
Antonio Jimenez-Pacheco et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
FABP4 as a key determinant of metastatic potential of ovarian cancer
Kshipra M. Gharpure et al.
NATURE COMMUNICATIONS (2018)
Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study
Jacob A. Gordon et al.
Oncotarget (2018)
Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?
Ana-Maria Enciu et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
Yifan Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation
Chih-Hao Lu et al.
ONCOGENE (2018)
A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells
Shogo Senga et al.
Oncotarget (2018)
The urea cycle enzymes act as metabolic suppressors in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
AGING-US (2018)
Onco-Multi-OMICS Approach: A New Frontier in Cancer Research
Sajib Chakraborty et al.
BIOMED RESEARCH INTERNATIONAL (2018)
The interplay between mutant p53 and the mevalonate pathway
Alejandro Parrales et al.
CELL DEATH AND DIFFERENTIATION (2018)
The current evidence on statin use and prostate cancer prevention: are we there yet?
Mahmoud A. Alfaqih et al.
NATURE REVIEWS UROLOGY (2017)
The emerging role of obesity, diet and lipid metabolism in prostate cancer
Matteo Ferro et al.
FUTURE ONCOLOGY (2017)
Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer
Barbra A. Dickerman et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer
Hui-Ming Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study
Pawel Derezinski et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation
Yadi Wu et al.
NATURE COMMUNICATIONS (2017)
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
Tongzheng Liu et al.
NATURE COMMUNICATIONS (2017)
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
Weinan Du et al.
NATURE COMMUNICATIONS (2017)
Stabilization of the transcription factors slug and twist by the deubiquitinase dub3 is a key requirement for tumor metastasis
Yiwei Lin et al.
ONCOTARGET (2017)
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
Massimo Papale et al.
ONCOTARGET (2017)
The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation
Cristina Bianchi et al.
ONCOTARGET (2017)
High Cholesterol/Low Cholesterol: Effects in Biological Membranes: A Review
Witold K. Subczynski et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2017)
Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5
Ranjana Mitra et al.
BMC CANCER (2017)
LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma
Sei Naito et al.
BRITISH JOURNAL OF CANCER (2017)
Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts
J. A. Gordon et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Statins and survival outcomes in patients with metastatic renal cell carcinoma
Rana R. Mckay et al.
EUROPEAN JOURNAL OF CANCER (2016)
Long-term Use of Statins and Risk of Renal Cell Carcinoma: A Population-based Case-Control Study
Anton Pottegard et al.
EUROPEAN UROLOGY (2016)
Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division
Ankur A. Gholkar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction
Margherita Gigante et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
Alejandro Parrales et al.
NATURE CELL BIOLOGY (2016)
Statin use and kidney cancer outcomes: A propensity score analysis
Madhur Nayan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer
Xiangyan Li et al.
ONCOTARGET (2016)
Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer
Jia Li et al.
SCIENTIFIC REPORTS (2016)
High expression of Fatty Acid-Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells
Koichiro Kawaguchi et al.
FEBS OPEN BIO (2016)
High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma
Jianfeng Wang et al.
PLOS ONE (2016)
Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma
Kosuke Saito et al.
SCIENTIFIC REPORTS (2016)
The multifaceted roles of fatty acid synthesis in cancer
Florian Roehrig et al.
NATURE REVIEWS CANCER (2016)
From big data analysis to personalized medicine for all: challenges and opportunities
Akram Alyass et al.
BMC MEDICAL GENOMICS (2015)
Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies
Liu YuPeng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Ariana Znaor et al.
EUROPEAN UROLOGY (2015)
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer
Giuseppe Lucarelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
Margherita Gigante et al.
MEDICINE (2015)
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma
Giuseppe Lucarelli et al.
MEDICINE (2015)
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer
Takayuki Goto et al.
PROSTATE (2015)
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma
Samuel D. Kaffenberger et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma
Jiancheng Zhou et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy
Boyd R. Viers et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance
Ottavio de Cobelli et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: Results from the North-American case-control study Prostate Cancer & Environment Study
Katharina Boehm et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations
Xiangyan Li et al.
ONCOTARGET (2015)
Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer
Lauren C. Harshman et al.
JAMA ONCOLOGY (2015)
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population
Alberto Breda et al.
WORLD JOURNAL OF UROLOGY (2015)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
Giuseppe Lucarelli et al.
DISEASE MARKERS (2014)
SET8 methyltransferase activity during the DNA double-strand break response is required for recruitment of 53BP1
Stanimir Dulev et al.
EMBO REPORTS (2014)
Lipogenesis in cancer progression (Review)
Catherine Mounier et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The Association between Statin Medication and Progression after Surgery for Localized Renal Cell Carcinoma
Robert J. Hamilton et al.
JOURNAL OF UROLOGY (2014)
Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling
Xiangyan Li et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
Antonio Vavallo et al.
MEDICINE (2014)
Palmitate-induced Activation of Mitochondrial Metabolism Promotes Oxidative Stress and Apoptosis in H4IIEC3 Rat Hepatocytes
Robert A. Egnatchik et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
A Novel Three Serum Phospholipid Panel Differentiates Normal Individuals from Those with Prostate Cancer
Nima Patel et al.
PLOS ONE (2014)
Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-Reoxygenation
Karim Bensaad et al.
CELL REPORTS (2014)
Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1
Byron H. Lee et al.
CANCER RESEARCH (2013)
Positive feedback loop and synergistic effects between hypoxia-inducible factor-2 and stearoylCoA desaturase-1 promote tumorigenesis in clear cell renal cell carcinoma
Yujian Zhang et al.
CANCER SCIENCE (2013)
Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma
Christina A. von Roemeling et al.
CLINICAL CANCER RESEARCH (2013)
Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer
Carlo Buonerba et al.
FUTURE ONCOLOGY (2013)
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano et al.
GENES & DEVELOPMENT (2013)
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
Jurre J. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma
Marwa E. Elsherbiny et al.
PROGRESS IN LIPID RESEARCH (2013)
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials
Huseyin Naci et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
Cholesterol and the development of clear-cell renal carcinoma
Harry A. Drabkin et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Lipid metabolism in cancer
Claudio R. Santos et al.
FEBS JOURNAL (2012)
Very long-chain fatty acids: elongation, physiology and related disorders
Akio Kihara
JOURNAL OF BIOCHEMISTRY (2012)
Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells
Gui Xian Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Analysis of Renal Cell Carcinoma as a First Step for Developing Mass Spectrometry-Based Diagnostics
Kentaro Yoshimura et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2012)
Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
Wen-Chin Huang et al.
MOLECULAR CANCER RESEARCH (2012)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids
Paul Mason et al.
PLOS ONE (2012)
The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
Teemu J. Murtola et al.
PLOS ONE (2012)
Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics
Xinchun Zhou et al.
PLOS ONE (2012)
Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes
Jonathan L. Wright et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Body Mass Index, Prostate Cancer-Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis
Yin Cao et al.
CANCER PREVENTION RESEARCH (2011)
Pilot Trial of Bone-Targeted Therapy Combining Zoledronate With Fluvastatin or Atorvastatin for Patients With Metastatic Renal Cell Carcinoma
George E. Manoukian et al.
CLINICAL GENITOURINARY CANCER (2011)
The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility
Michelle de la Vega et al.
NATURE COMMUNICATIONS (2011)
Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer
M. D. Brown et al.
BRITISH JOURNAL OF CANCER (2010)
Statin Medication Use and the Risk of Biochemical Recurrence After Radical Prostatectomy Results From the Shared Equal Access Regional Cancer Hospital (SEARCH) Database
Robert J. Hamilton et al.
CANCER (2010)
The Deubiquitinating Enzyme USP17 Is Highly Expressed in Tumor Biopsies, Is Cell Cycle Regulated, and Is Required for G1-S Progression
Cheryl McFarlane et al.
CANCER RESEARCH (2010)
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
Meng-Lei Zhu et al.
CANCER RESEARCH (2010)
Statin Use and Risk of Prostate Cancer Recurrence in Men Treated With Radiation Therapy
Ruchika Gutt et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice
Vanessa Fritz et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol
Elin Thysell et al.
PLOS ONE (2010)
Biochemical and physiological function of stearoyl-CoA desaturase
Chad M. Paton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism
Kenji Tamura et al.
CANCER RESEARCH (2009)
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
Jocelyn S. Kasper et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The emerging functions and mechanisms of mammalian fatty acid-binding proteins
Judith Storch et al.
ANNUAL REVIEW OF NUTRITION (2008)
A novel fatty acid-binding protein (FABP) gene resulting from tandem gene duplication in mammals: transcription in rat retina and testis
Rong-Zong Liu et al.
GENOMICS (2008)
Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma
Akio Horiguchi et al.
JOURNAL OF UROLOGY (2008)
Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells
Akio Horiguchi et al.
JOURNAL OF UROLOGY (2008)
Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3
Johannes Noe et al.
DRUG METABOLISM AND DISPOSITION (2007)
ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells
Tsutomu Kobayashi et al.
FEBS LETTERS (2007)
Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality
Margaret E. Wright et al.
CANCER (2007)
Body size and composition and prostate cancer risk: systematic review and meta-regression analysis
Robert J. MacInnis et al.
CANCER CAUSES & CONTROL (2006)
Fatty acid elongases in mammals: Their regulation and roles in metabolism
Andreas Jakobsson et al.
PROGRESS IN LIPID RESEARCH (2006)
The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism
A Chmurzynska
JOURNAL OF APPLIED GENETICS (2006)
Lipid class distribution of fatty acids including conjugated linoleic acids in healthy and cancerous parts of human kidneys
K Hoffmann et al.
LIPIDS (2005)
Fatty acid-binding proteins - insights from genetic manipulations
NH Haunerland et al.
PROGRESS IN LIPID RESEARCH (2004)
Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase
J Fang et al.
CURRENT BIOLOGY (2002)
Share Paper
